{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:01:55Z","timestamp":1783728115995,"version":"3.55.0"},"reference-count":44,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2007,6,9]],"date-time":"2007-06-09T00:00:00Z","timestamp":1181347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Small Animal Practice"],"published-print":{"date-parts":[[2007,7]]},"abstract":"<jats:p><jats:bold>O<jats:sc>bjectives<\/jats:sc>:<\/jats:bold><jats:bold>To determine the efficacy and safety of cefovecin in the treatment of bacterial skin infections in dogs.<\/jats:bold><\/jats:p><jats:p><jats:bold>M<jats:sc>ethod<\/jats:sc>:<\/jats:bold><jats:bold>Dogs with superficial or deep pyoderma or wounds\/abscesses were enrolled in three separate studies. Dogs (354) were randomised to treatment and received either cefovecin administered by subcutaneous injection at 14 day intervals, as clinically necessary, or amoxicillin\/clavulanic acid as oral tablets twice daily for 14 days. Courses of treatment were repeated at 14 day intervals up to a total of four courses. Clinicians responsible for assessing lesions were masked to treatment allocation. Only animals where the presence of a pretreatment bacterial pathogen was confirmed were included in the analysis of efficacy. Cases were evaluated for clinical efficacy at 28 days after initiation of the final course of treatment. Clinical efficacy was assessed by scoring the clinical signs typical of skin infections.<\/jats:bold><\/jats:p><jats:p><jats:bold>R<jats:sc>esults<\/jats:sc>:<\/jats:bold><jats:bold>Cefovecin demonstrated statistical non\u2010inferiority compared with amoxicillin\/clavulanic acid for all three clinical diagnoses; for cefovecin, up to 96\u00b79 per cent efficacy was observed versus 92\u00b75 per cent for amoxicillin\/clavulanic acid.<\/jats:bold><\/jats:p><jats:p><jats:bold>C<jats:sc>linical<\/jats:sc>S<jats:sc>ignificance<\/jats:sc>:<\/jats:bold><jats:bold>Cefovecin was shown to be as effective as amoxicillin\/clavulanic acid administered orally in the treatment of bacterial skin infections in dogs. Cefovecin offers the additional benefit of eliminating owner non\u2010compliance.<\/jats:bold><\/jats:p>","DOI":"10.1111\/j.1748-5827.2007.00363.x","type":"journal-article","created":{"date-parts":[[2007,6,9]],"date-time":"2007-06-09T08:20:26Z","timestamp":1181377226000},"page":"378-386","source":"Crossref","is-referenced-by-count":22,"title":["Clinical efficacy and safety of cefovecin in the treatment of canine pyoderma and wound infections"],"prefix":"10.1111","volume":"48","author":[{"given":"M. R.","family":"Stegemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Coati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. A.","family":"Passmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sherington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,6,9]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-0813.1996.tb13774.x"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.121829"},{"key":"e_1_2_6_4_1","first-page":"876","article-title":"Occurrence of anaerobic bacteria in diseases of the dog and cat","volume":"40","author":"Berg J. N.","year":"1979","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_6_5_1","first-page":"1307","article-title":"Identification of the major coagulase\u2010positive Staphylococcus sp. of dogs as Staphylococcus intermedius","volume":"45","author":"Berg J. N.","year":"1984","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3164.1999.00181.x"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-5827.1999.tb03077.x"},{"key":"e_1_2_6_8_1","first-page":"124","article-title":"Species of Staphylococcus isolated from animal infections","volume":"74","author":"Cox H. U.","year":"1984","journal-title":"Cornell Veterinarian"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(95)00053-D"},{"key":"e_1_2_6_10_1","unstructured":"EMEA(2000)Points to Consider on Switching Between Superiority and Non\u2010Inferiority (CPMP\/EWP\/482\/99). London UK:The European Agency for the Evaluation of Medicinal Products Committee for Proprietary Medicinal Products (CPMP)"},{"key":"e_1_2_6_11_1","unstructured":"EMEA(2001)Guideline on Statistical Principles for Veterinary Clinical Trials (EMEA\/CVMP\/816\/00\u2010FINAL). London UK:The European Agency for the Evaluation of Medicinal Products Committee for Veterinary Medicinal Products (CVMP)"},{"key":"e_1_2_6_12_1","unstructured":"EMEA(2006)Convenia. European Public Assessment Report: Scientific Discussion.www.emea.eu. Accessed February 2007"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/49.1.77"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-5827.1999.tb03781.x"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3164.1999.00186.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.1994.tb00015.x"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3164.1998.00093.x"},{"key":"e_1_2_6_18_1","first-page":"240","volume-title":"Small Animal Dermatology \u2013 A Practical Guide to the Diagnosis and Management of Skin Diseases in Dogs and Cats","author":"Hill P. B","year":"2002"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/vr.158.16.533"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/vr.158.16.533"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0007-1935(87)90002-9"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3164.1999.00179.x"},{"key":"e_1_2_6_23_1","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.2460\/javma.1997.210.11.1610","article-title":"Organisms isolated from dogs and cats with anaerobic infections and susceptibility to selected antimicrobial agents","volume":"210","author":"Jang S. S.","year":"1997","journal-title":"Journal of American Veterinary Medical Association"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.1991.tb00127.x"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.1996.tb00242.x"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/vr.141.17.439"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-5827.1991.tb00960.x"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3164.1999.00183.x"},{"key":"e_1_2_6_29_1","first-page":"238","article-title":"Clinical efficacy of cefalexin administered once or twice daily by oral route in the treatment of pyoderma in dogs. Abstract presented at the 18th Annual Congress of the European Small Animal Veterinary Dermatology","volume":"14","author":"Maynard L.","year":"2003","journal-title":"Veterinary Dermatology"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.1993.tb00184.x"},{"key":"e_1_2_6_31_1","first-page":"M31","volume-title":"Approved Standard","author":"NCCLS","year":"2002"},{"key":"e_1_2_6_32_1","volume-title":"Approved Standard","author":"NCCLS","year":"2003"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I"},{"key":"e_1_2_6_34_1","first-page":"159","volume-title":"BSAVA Manual of Small Animal Dermatology","author":"Noli C","year":"2003"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3164.1999.00176.x"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.2460\/javma.2001.218.381"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.1990.tb00090.x"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3164.2001.00195.x"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0147-9571(97)00026-X"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.5326\/0380407"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3164.1999.00170.x"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-7216-7618-0.50008-0"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00077-06"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.2006.00801.x"},{"key":"e_1_2_6_45_1","unstructured":"VICH(2000)International Co\u2010operation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products Good Clinical Practice June 2000 Effective 01 July 2001.http:\/\/vich.eudra.org\/. Accessed February 2007"}],"container-title":["Journal of Small Animal Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1748-5827.2007.00363.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1748-5827.2007.00363.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:33:09Z","timestamp":1707957189000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1748-5827.2007.00363.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,9]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["10.1111\/j.1748-5827.2007.00363.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1748-5827.2007.00363.x","archive":["Portico"],"relation":{},"ISSN":["0022-4510","1748-5827"],"issn-type":[{"value":"0022-4510","type":"print"},{"value":"1748-5827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,9]]}}}